#United States #San Diego #Shareholders Foundation #Charming Medical #NASDAQ MCTA

Investors of Charming Medical Limited: A Call to Action

Investors who have incurred losses with Charming Medical Limited, trading under NASDAQ: MCTA, are facing a tough battle. A significant lawsuit has been filed concerning alleged violations of securities laws that could have impacted their investments. This notice aims to inform affected investors about the ongoing legal situation and the avenues available for recourse.

Background of the Case

On February 3, 2026, the Shareholders Foundation, Inc. publicly announced that a lawsuit is pending against Charming Medical Limited. This stems from accusations that the company made misleading statements and failed to disclose critical information related to fraudulent activities. Specifically, the allegations suggest involvement in a fraudulent stock promotion scheme leveraging misinformation on social media, and the impersonation of financial professionals.

Due to these allegations, insiders and affiliates may have manipulated the stock price using offshore accounts. This means that during a period of inflated stock prices, shares could have been dumped, resulting in significant losses for individual investors.

Importance of Timeliness

It's crucial for investors to act swiftly as there are limited opportunities and tight deadlines associated with this lawsuit. The deadline for affected investors to contact the Shareholders Foundation is February 17, 2026. Those looking to take legal action or simply acquire more information are encouraged to reach out via email at [email protected] or by phone at +1 (858) 779-1554.

Understanding the Allegations

The heart of the lawsuit lies in several specific claims against Charming Medical. Plaintiffs allege that the company:
1. Made False or Misleading Statements: Investors were not informed about the truth surrounding the company's practices or financial health.
2. Failed to Disclose Major Risks: Key information regarding the ongoing fraudulent stock promotion scheme was not shared with the public and investors.
3. Engaged in Coordinated Stock Dumping: Insiders potentially exploited social media's reach to inflate their stock's value artificially, only to execute a coordinated sell-off. This manipulation could mislead investors into believing in the company's legitimacy.

These points represent severe breaches of trust that can have lasting impacts on investor finances and the integrity of market practices.

The Role of the Shareholders Foundation

The Shareholders Foundation, Inc. serves as a specialized entity devoted to assisting investors in situations like this one. Its role extends beyond merely filing claims; it also involves conducting thorough research related to shareholder issues and educating investors about various legal actions, settlements, and other significant legal developments within the financial market. However, it’s essential to note that the Shareholders Foundation is not a law firm, and the information provided is intended purely for public awareness and not as legal advice.

For investors of Charming Medical, this is a critical moment. By coming together and seeking assistance via the Shareholders Foundation, those affected may have the opportunity to recoup some of their losses and hold those responsible accountable.

Conclusion

In light of these developments surrounding Charming Medical Limited's stock, it is more important than ever for investors to remain informed and proactive. Those who believe they might have been affected should take immediate action to explore their options. The legal landscape can be daunting, but there are resources available to assist investors through these challenging times. Don't hesitate to reach out to the Shareholders Foundation to learn more about your rights and possible next steps.